NCT00716053View on ClinicalTrials.gov

Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

PHASE3WithdrawnINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Advanced Upper Lobe Predominant Emphysema
Interventions
DRUG

BLVR

BLVR 20 mL

Sponsors

Lead Sponsor

Aeris Therapeutics
All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT00716053 - Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema | Biotech Hunter | Biotech Hunter